Valuation: NeuroPace, Inc.

Market Cap 498M 432M 405M 369M 694M 47.53B 705M 4.77B 1.86B 23.79B 1.87B 1.83B 79.37B P/E 2026 *
-28.7x
P/E 2027 * -53.8x
Enterprise Value 521M 452M 424M 386M 727M 49.75B 738M 4.99B 1.95B 24.9B 1.96B 1.91B 83.07B EV / Sales 2026 *
5.2x
EV / Sales 2027 * 4.19x
Free-Float
82.96%
Yield 2026 *
-
Yield 2027 * -
1 day-0.34%
1 week+4.39%
Current month+12.57%
1 month-15.25%
3 months-8.22%
6 months-3.59%
Current year-6.02%
1 week 14.16
Extreme 14.16
15.38
1 month 12.66
Extreme 12.66
16.8
Current year 12.47
Extreme 12.47
19.6
1 year 8.17
Extreme 8.17
19.6
3 years 4.21
Extreme 4.21
19.6
5 years 1.22
Extreme 1.22
24.65
10 years 1.22
Extreme 1.22
27.38
Manager TitleAgeSince
Chief Executive Officer 58 2023-07-09
Director of Finance/CFO 53 2025-06-19
Chief Tech/Sci/R&D Officer - 2024-09-03
Director TitleAgeSince
Director/Board Member 57 2012-12-31
Chairman 84 1997-11-30
Director/Board Member 46 2021-03-31
Date Insider Type Main position Quantity % Market Cap.
6/19/26 Free

Director

789 0.0023%
5/15/26 Free

Chief Financial Officer

61,620 0.1815%
2/27/26 Tax

Chief Executive Officer

1,126 0.0034%
Change 5-day change 1-year change 3-year change Capi.($)
-0.34%+4.39%+55.69%+222.44% 500M
-1.18%+2.74%+22.92%+9.58% 223B
-0.92%+1.96%-2.51%-20.17% 145B
0.00%+7.37%-16.81%+31.78% 142B
+0.53%+4.85%-49.57%+1.29% 74.52B
-0.53%+3.63%+19.16%+16.56% 53.63B
+0.03%-0.15%-16.01%-17.27% 50.14B
+0.71%+5.62%+24.11%+17.68% 41.87B
-0.63%+3.46%+39.31%+41.78% 40.89B
+2.09%+4.95%-2.04%+3.07% 32.65B
Average +0.17%+3.98%+7.42%+30.68% 80.36B
Weighted average by Cap. -0.20%+3.83%+1.83%+8.09%

Financials

2026 *2027 *
Net sales 100M 86.87M 81.43M 74.25M 140M 9.56B 142M 959M 374M 4.79B 376M 368M 15.97B 123M 106M 99.7M 90.91M 171M 11.71B 174M 1.17B 458M 5.86B 461M 451M 19.55B
Net income -17.35M -15.04M -14.1M -12.85M -24.19M -1.66B -24.57M -166M -64.8M -829M -65.13M -63.72M -2.76B -9.63M -8.35M -7.83M -7.14M -13.43M -919M -13.65M -92.18M -35.99M -460M -36.17M -35.39M -1.54B
Net Debt 23.21M 20.12M 18.86M 17.2M 32.36M 2.22B 32.88M 222M 86.7M 1.11B 87.14M 85.26M 3.7B 16.02M 13.88M 13.02M 11.87M 22.33M 1.53B 22.69M 153M 59.83M 765M 60.14M 58.84M 2.55B
Logo NeuroPace, Inc.
NeuroPace, Inc. is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. The Company's RNS System is a brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients living with drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders. The Company's RNS System includes its RNS neurostimulator, its cortical strip leads and depth leads, and its Patient Remote Monitor, as well as other implantable and non-implantable accessories. The Company's product offerings also include Physician Tablet, Patient Data Management System (PDMS) and nSight Platform, which facilitate ongoing patient monitoring and streamline patient support. The PDMS is an online database.
Employees
220
Date Price Change Volume
26-08-13 US$14.51 -0.34% 112,791
26-08-12 US$14.56 -3.26% 186,273
26-08-11 US$15.05 +1.14% 248,341
26-08-10 US$14.88 +0.34% 234,544
26-08-07 US$14.83 +6.69% 201,386
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
14.51USD
Average target price
20.22USD
Spread / Average Target
+39.37%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NPCE Stock